These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31482504)

  • 1. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
    Bowden SA; Foster BL
    Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA; Foster BL
    Drug Des Devel Ther; 2018; 12():3147-3161. PubMed ID: 30288020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphatasia: An overview For 2017.
    Whyte MP
    Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia.
    Dahir KM; Shannon A; Dunn D; Voegtli W; Dong Q; Hasan J; Pradhan R; Pelto R; Pan WJ
    J Bone Miner Res; 2024 Sep; 39(10):1412-1423. PubMed ID: 39135540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP; McAlister WH; Mumm S; Bierhals AJ
    Bone; 2019 May; 122():231-236. PubMed ID: 30825650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
    Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
    Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
    Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
    JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP
    J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the
    Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML
    Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ
    Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Infantile Hypophosphatasia on Human Dental Tissue.
    Wölfel EM; von Kroge S; Matthies L; Koehne T; Petz K; Beikler T; Schmid-Herrmann CU; Kahl-Nieke B; Tsiakas K; Santer R; Muschol NM; Herrmann J; Busse B; Amling M; Rolvien T; Jandl NM; Barvencik F
    Calcif Tissue Int; 2023 Mar; 112(3):308-319. PubMed ID: 36414794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D
    Kinoshita Y; Mohamed FF; Amadeu de Oliveira F; Narisawa S; Miyake K; Foster BL; Millán JL
    J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
    Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
    Whyte MP
    Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkaline Phosphatase Replacement Therapy.
    Bianchi ML; Vai S
    Adv Exp Med Biol; 2019; 1148():201-232. PubMed ID: 31482501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health.
    Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP
    Bone; 2020 Jul; 136():115322. PubMed ID: 32200022
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.